On the recordApril 23, 2018
We have discussed the frustration we both share about the anti-competitive tactics used by brand drug companies to deny the sale of samples to generic manufacturers.
Source
congress.govWe have discussed the frustration we both share about the anti-competitive tactics used by brand drug companies to deny the sale of samples to generic manufacturers.
Leahy expresses shared frustration over brand drug companies' tactics against generics.
Share
More from Patrick Leahy
Congress was the original classification authority (OCA). It let that power essentially slip away to the Executive Branch.
I can say with absolute certainty that the proposed rules directly conflict with the legislation on a variety of matters, especially on provisions that limit access to the PTAB.
I can say with absolute certainty that the proposed rules directly conflict with the legislation on a variety of matters, especially on provisions that limit access to the PTAB.